Topline
The Supreme Court will hear oral arguments Tuesday in two cases concerning the approval of abortion drug mifepristone, potentially limiting access to the medication as it’s become a more prominent abortion method in the wake of the high court overturning Roe v. Wade in June 2022.
The abortion-inducing drug mifepristone can now be dispensed at pharmacies that choose to provide … [+]
Key Facts
The Supreme Court will hear cases brought by the Food and Drug Administration and mifepristone manufacturer Danco Laboratories over…
Continue Reading
News Source: www.forbes.com